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 Buffered dextrose 5% – an alternative analgesia 
 M. L. Swee 1  , H. E. Liu 1 , Y. Y. Jasmine Sze 1 , H. N. Kooi 1 , H. C. Siew 1 , 
S. Shantene 1 , M. Nadiah 1 , M. Asmah 1 , C. G. Suk 1  
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 Background/Purpose: Chronic pain around neck and upper limbs 
(NUL) among patients with rheumatic and musculoskeletal disease 
(RMD) is challenging to handle. Dr John Lyftogt has established the 
use of buffered dextrose 5% with pH of 7.4 (BD5%) in Perineural 
injection therapy (PIT) to treat such condition with success. 
 Our primary objective is to assess pain score reduction (PSR) in 
Numerical Rating scale (NRS) after PIT in this region. Secondary ob-
jective is to assess percentage of patients who achieved at least 50% 
PSR at the end of treatment. 
 Methods: Patients with NUL pain who received PIT in 2019 and 
had followed up for 12 months were reviewed. PIT was performed 
by serial injection of BD5% along the superficial nerve(s) under-
neath the skin using 30G, 1cm hypodermic needle. Patients with 
pain score not recorded or still undergoing PIT were excluded. 
PSR before and after series of treatments were analysed using 
paired T test. 
 Results: 21 patients with NUL pain were treated with total of 61 PIT. 
Mean age was 58.1. 76.2% (n = 16) were female. 57.1% (n = 12) had 
shoulder tendinopathy with or without tear, 33.3% (n = 7) had fibro-
myalgia while 9.5% (n = 2) had cervical spondylosis. 
 Baseline pain score was 7.0 ± 1.4, duration of pain was 1.8 ± 1.6 
years. Average 2.9 ± 1.5 times of PIT were performed. 19% (n = 4) 
had one PIT, 23% (n = 5) needed two while 29% (n = 6) needed three 
PIT. Distribution of cases according to number of PIT as shown in 
Figure 1. 
 Pain score reduced to 2.9 ± 1.7, 2.1 ± 1.4 and subsequently 1.4 ± 1.1 
following first, second and third PIT. On average, PSR was 6.0 ± 2.2 
(p = 0.0001). The effect lasted for 5.7 ± 4.2 months. No complica-
tions were observed. 
 100% of them demonstrated 50% or more PSR. 
 Conclusion: Buffered dextrose 5% in perineural injection therapy al-
leviates NUL pain significantly. This is a good and safe alternative 
treatment for RMD patients with NUL pain. 
 Buffered dextrose 5% - the sweet solution for 
chronic low back pain 
 M. L. Swee 1  , S. Shantene 1 , H. E. Liu 1 , Y. Y. Jasmine Sze 1 , H. N. Kooi 1 , 
H. C. Siew 1 , M. Nadiah 1 , M. Asmah 1 , C. G. Suk 1  
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 Background/Purpose: Chronic low back pain (CLBP) is one of the 
constant struggle among patients with rheumatic and musculoskel-
etal disease (RMD). Dr John Lyftogt had used buffered dextrose 5% 
with pH of 7.4 (BD5%) via caudal epidural injection (CEI) to treat 
CLBP successfully. 
 Our primary objective is to assess pain score reduction (PSR) in 
Numerical Rating scale (NRS) after CEI. Secondary objective is to 
assess percentage of patients who achieved at least 50% PSR at the 
end of treatment. 
 Methods: Patients with CLBP who received CEI in 2019 and had fol-
lowed up for 12 months were reviewed. CEI was performed by giv-
ing 10 mL of BD5% at caudal epidural region via 26G, 1cm needle. 
Patients with pain score not recorded or still undergoing CEI were 
excluded. PSR before and after series of treatments were analysed 
using paired T test. 
 Results: 35 patients received total of 127 CEI for CLBP. Mean age 
was 62.1 years and 80% (n = 28) were females. 80% (n = 28) had 
mechanical low back pain due to spondylosis, prolapsed interver-
tebral disc, spinal stenosis and spondylolisthesis. 14.3% (n = 5) had 
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 Lupus nephritis presenting as a renal hematoma 
in a Filipino female patient: a case report 
 R. Ramirez 1  
 1 Valenzuela Medical Center, Valenzuela City, Philippines 
 Lupus nephritis is an inflammation of the kidneys caused by systemic 
lupus erythematosus (SLE). It is the most frequent complication of 
SLE. There is a wide spectrum of clinical manifestations of lupus ne-
phritis however; renal hematoma is a rare presentation. The author 
presents a Filipino female patient admitted for flank pain and was 
subsequently diagnosed with Lupus Nephritis. 
 Case Presentation: This is a case of a 32- year old Filipino woman, 
who had presented with a recurrent, progressive flank pain associ-
ated with intermittent pedal edema, fatigue, macular rash, and fever. 
Computed tomography of the abdomen revealed diffuse subacute 
capsular hematoma of the right kidney. Subsequent diagnostic 
exams revealed anemia, leucopenia, elevated creatinine, hematuria, 
low C3, elevated ANA, Anti- dsDNA and Anti- Smith. She was man-
aged as a case of Lupus Nephritis, and was given Methylprednisone 
pulse 1 gram for 3 days and Cyclophosphamide 750mg IV infu-
sion thereafter. Patient improved with resolution of renal hema-
toma and pedal edema. She was maintained on Prednisone and IV 
Cyclophosphamide. 
 Conclusion: Our experience demonstrates that Lupus Nephritis may 
present atypically. It exhibits unusual spectrum that may progressed 
to severe clinical manifestations. Steroids and IV Cyclophosphamide 
bring on remission of even severe Lupus Nephritis. 
 Acute pancreatitis as an initial presentation of 
SLE: a case report 
 B. Sachdev Manjit Singh 1  , C. Teh 1 , S. Chuah 1 , Y. Cheong 1 , S. Wan 1 , 
A. Jobli 2  
 1 Rheumatology Unit, Department Of Medicine, Sarawak General 
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 Background:  SLE is a complex multi- systemic autoimmune disease 
capable of affecting any organ system with varying presentations. 
Abdominal pain is a common manifestation of SLE and is reported 
to occur in about 8% to 40% of patients with SLE. The causes of 
abdominal pain are varied and require accurate assessment. Acute 
Pancreatitis is a cause of abdominal pain and is a rare initial SLE 
presentation. It is characterized by abdominal pain and raised serum 
amylase levels. We would like to report a patient diagnosed with SLE 
following an initial presentation of Acute Pancreatitis, which was 
complicated with a pancreatic pseudocyst. 
 Case Report: The patient is an 18- year- old lady with no previous 
known medical illness who presented with a one day history of acute 
central abdominal pain radiating to the back. This was preceded by a 
two week history of fever and non- productive cough. Further history 
revealed that she had alopecia, malar rash and painless oral ulcers 
one year before this presentation but did not seek medical attention. 
Physical examination revealed a tender and distended abdomen. 
Blood investigations showed leukopenia, elevated amylase with a 
positive Anti- nuclear antibody, and coombs test. She was admitted 
to the ICU and treated with intravenous cyclophosphamide, methyl-
prednisolone, immunoglobulin, and antibiotics. During her follow- up 
a month after discharge, she was found to have recurrent abdominal 
pain and distension. A repeated CT Abdomen showed a pancreatic 
pseudocyst, and she underwent an endoscopic cystogastrostomy. 
Currently, she is on regular follow- up and is currently maintained on 
Hydroxychloroquine, Azathioprine, and Prednisolone. 
 Conclusion: In summary, Acute Pancreatitis is a relatively rare initial 
manifestation of SLE. The causes of Acute Pancreatitis are varied, 
and it is essential to recognize and differentiate Acute Pancreatitis 
due to active SLE from other causes as it may affect treatment deci-
sions and subsequent mortality outcomes. 
 Catastrophic antiphospholipid syndrome 
precipitated by acute leukaemia: a case report 
 B. Sachdev Manjit Singh 1  , W. Lee 1 , K. Lee 1 , Y. Cheong 1 , S. Wan 1 , C. 
Teh 1  
 1 Sarawak General Hospital, Kuching, Malaysia 
 Background: Catastrophic Antiphospholipid Syndrome (CAPS) rarely 
occurs in patients with Antiphospholipid Syndrome (APLS). It is an 
accelerated and devastating form of APLS characterized by multiple 
thromboses affecting mainly small vessels resulting in multi- organ 
failure. It has a high mortality rate despite aggressive treatment. 
Precipitating factors for CAPS include infections, surgery, and ma-
lignancy. We herein report a patient with SLE and secondary APLS 
diagnosed with CAPS precipitated by acute leukemia. 
 Case Report: The patient is a 63- year- old lady with a history of hy-
pertension, dyslipidemia, and SLE with secondary APLS. She pre-
sented with acute right lower limb pain associated with coldness 
and numbness. Examination revealed a cold, pale right lower limb 
with reduced sensation and non- palpable pulses over the right fem-
oral, popliteal, dorsalis pedis, and posterior tibialis. CT Angiogram 
of the bilateral lower limbs revealed a long segment thrombosis in 
the mid and distal right Superficial Femoral Artery. A diagnosis of 
Acute Right lower limb Ischemia was made. She was treated with 
intravenous heparin and underwent a right lower limb femoral em-
bolectomy. Postoperative, the right lower limb pulses were palpable 
but became absent again on day two. A repeated CT Aorta revealed 
a short segment mural thrombus at the infrarenal abdominal aorta 
with minimal mural thrombus at the bilateral common iliac and com-
mon femoral arteries. 
 The vascular team proceeded with a bilateral femoral embolectomy 
for worsening symptoms but was complicated with hypotension re-
quiring inotropic support and ICU admission. Methylprednisolone 
